Literature DB >> 25461267

Cerebral responses and role of the prefrontal cortex in conditioned pain modulation: an fMRI study in healthy subjects.

Volodymyr B Bogdanov1, Alessandro Viganò2, Quentin Noirhomme3, Olena V Bogdanova4, Nathalie Guy5, Steven Laureys3, Perry F Renshaw4, Radhouane Dallel5, Christophe Phillips6, Jean Schoenen7.   

Abstract

The mechanisms underlying conditioned pain modulation (CPM) are multifaceted. We searched for a link between individual differences in prefrontal cortex activity during multi-trial heterotopic noxious cold conditioning and modulation of the cerebral response to phasic heat pain. In 24 healthy female subjects, we conditioned laser heat stimuli to the left hand by applying alternatively ice-cold or lukewarm compresses to the right foot. We compared pain ratings with cerebral fMRI BOLD responses. We also analyzed the relation between CPM and BOLD changes produced by the heterotopic cold conditioning itself, as well as the impact of anxiety and habituation of cold-pain ratings. Specific cerebral activation was identified in precuneus and left posterior insula/SII, respectively, during early and sustained phases of cold application. During cold conditioning, laser pain decreased (n=7), increased (n=10) or stayed unchanged (n=7). At the individual level, the psychophysical effect was directly proportional to the cold-induced modulation of the laser-induced BOLD response in left posterior insula/SII. The latter correlated with the BOLD response recorded 80s earlier during the initial 10-s phase of cold application in anterior cingulate, orbitofrontal and lateral prefrontal cortices. High anxiety and habituation of cold pain were associated with greater laser heat-induced pain during heterotopic cold stimulation. The habituation was also linked to the early cold-induced orbitofrontal responses. We conclude that individual differences in conditioned pain modulation are related to different levels of prefrontal cortical activation by the early part of the conditioning stimulus, possibly due to different levels in trait anxiety.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain imaging; Conditioned pain modulation; Prefrontal cortex

Mesh:

Year:  2014        PMID: 25461267      PMCID: PMC5502003          DOI: 10.1016/j.bbr.2014.11.028

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  58 in total

1.  Abstract reward and punishment representations in the human orbitofrontal cortex.

Authors:  J O'Doherty; M L Kringelbach; E T Rolls; J Hornak; C Andrews
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

2.  Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats.

Authors:  K A Sluka; M Deacon; A Stibal; S Strissel; A Terpstra
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

3.  Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder.

Authors:  Edith Normand; Stéphane Potvin; Isabelle Gaumond; Guylaine Cloutier; Jean-François Corbin; Serge Marchand
Journal:  J Clin Psychiatry       Date:  2010-08-10       Impact factor: 4.384

4.  A multisensory investigation of the functional significance of the "pain matrix".

Authors:  André Mouraux; Ana Diukova; Michael C Lee; Richard G Wise; Gian Domenico Iannetti
Journal:  Neuroimage       Date:  2010-10-12       Impact factor: 6.556

5.  Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls.

Authors:  Guang Hui Song; Vinod Venkatraman; Khek Yu Ho; Michael W L Chee; Khay Guan Yeoh; Clive H Wilder-Smith
Journal:  Pain       Date:  2006-07-18       Impact factor: 6.961

6.  Cerebral and cerebrospinal processes underlying counterirritation analgesia.

Authors:  Mathieu Piché; Marianne Arsenault; Pierre Rainville
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

7.  Temporal filtering of nociceptive information by dynamic activation of endogenous pain modulatory systems.

Authors:  Marc D Yelle; Yoshitetsu Oshiro; Robert A Kraft; Robert C Coghill
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

8.  The 'where' and the 'when' of the BOLD response to pain in the insular cortex. Discussion on amplitudes and latencies.

Authors:  Florence B Pomares; Isabelle Faillenot; Fabrice Guy Barral; Roland Peyron
Journal:  Neuroimage       Date:  2012-09-21       Impact factor: 6.556

9.  Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis.

Authors:  Michael Valet; Till Sprenger; Henning Boecker; Frode Willoch; Ernst Rummeny; Bastian Conrad; Peter Erhard; Thomas R Tolle
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

10.  Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis.

Authors:  D J Mayer; J C Liebeskind
Journal:  Brain Res       Date:  1974-03-15       Impact factor: 3.252

View more
  22 in total

1.  The medial temporal lobe in nociception: a meta-analytic and functional connectivity study.

Authors:  Lizbeth J Ayoub; Alexander Barnett; Aziliz Leboucher; Mitchell Golosky; Mary Pat McAndrews; David A Seminowicz; Massieh Moayedi
Journal:  Pain       Date:  2019-06       Impact factor: 6.961

2.  Cortical influences on brainstem circuitry responsible for conditioned pain modulation in humans.

Authors:  Andrew M Youssef; Vaughan G Macefield; Luke A Henderson
Journal:  Hum Brain Mapp       Date:  2016-04-22       Impact factor: 5.038

3.  Resting Functional Connectivity of the Periaqueductal Gray Is Associated With Normal Inhibition and Pathological Facilitation in Conditioned Pain Modulation.

Authors:  Daniel E Harper; Eric Ichesco; Andrew Schrepf; Johnson P Hampson; Daniel J Clauw; Tobias Schmidt-Wilcke; Richard E Harris; Steven E Harte
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

Review 4.  Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.

Authors:  Janie Damien; Luana Colloca; Carmen-Édith Bellei-Rodriguez; Serge Marchand
Journal:  Int Rev Neurobiol       Date:  2018-08-14       Impact factor: 3.230

5.  Altered Brain Structure and Functional Connectivity and Its Relation to Pain Perception in Girls With Irritable Bowel Syndrome.

Authors:  Ravi R Bhatt; Arpana Gupta; Jennifer S Labus; Lonnie K Zeltzer; Jennie C Tsao; Robert J Shulman; Kirsten Tillisch
Journal:  Psychosom Med       Date:  2019 Feb/Mar       Impact factor: 3.864

6.  A novel paradigm to evaluate conditioned pain modulation in fibromyalgia.

Authors:  Cynthia J Schoen; Jacob N Ablin; Eric Ichesco; Rupal J Bhavsar; Laura Kochlefl; Richard E Harris; Daniel J Clauw; Richard H Gracely; Steven E Harte
Journal:  J Pain Res       Date:  2016-09-26       Impact factor: 3.133

7.  Introducing descending control of nociception: a measure of diffuse noxious inhibitory controls in conscious animals.

Authors:  Kirsty Bannister; Mateusz W Kucharczyk; Thomas Graven-Nielsen; Frank Porreca
Journal:  Pain       Date:  2021-07-01       Impact factor: 7.926

8.  A combined DTI and resting state functional MRI study in patients with postherpetic neuralgia.

Authors:  Hui Dai; Chengcheng Jiang; Guanzuan Wu; Renjun Huang; Xiaohong Jin; Zhongshuai Zhang; Lina Wang; Yonggang Li
Journal:  Jpn J Radiol       Date:  2020-02-18       Impact factor: 2.701

9.  State-of-art neuroanatomical target analysis of high-definition and conventional tDCS montages used for migraine and pain control.

Authors:  Alexandre F DaSilva; Dennis Q Truong; Marcos F DosSantos; Rebecca L Toback; Abhishek Datta; Marom Bikson
Journal:  Front Neuroanat       Date:  2015-07-15       Impact factor: 3.856

10.  Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats.

Authors:  Xing-Xing Shi; Bai-Shuang Yin; Peng Yang; Hao Chen; Xin Li; Li-Xue Su; Hong-Gang Fan; Hong-Bin Wang
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.